Medical software platform for regulated healthcare ecosystems
BAYOOMED develops software for medical devices, digital therapeutics, and healthcare collaboration—operating in a heavily regulated space where compliance (ISO 13485, IEC 62304, FDA, MDR, GDPR, HIPAA) is non-negotiable. The tech stack reveals a traditional medical software foundation: Java, C++, C# on Windows/Android/iOS with Azure/AWS/GCP backend, plus web layers in Angular and Node.js. The engineering-heavy hiring mix (27 of 56 active roles) paired with only 3 legal hires signals either execution velocity ahead of compliance coverage or a company scaling development faster than regulatory infrastructure—a common tension in medtech startups.
BAYOOMED is a Darmstadt-based medical software company founded in 2021, operating at 51–200 employees across engineering, sales, product, design, legal, and operations. The company serves medtech, pharma, payors, and life sciences with solutions including the MedicalOne Connect platform—a pre-validated, multi-stakeholder collaboration system for patient apps, device integration (BLE, FHIR), and real-world evidence collection. Beyond MedicalOne, the portfolio includes digital therapeutics (DTx), access-and-identity management systems, and risk-management tools. The company reports over 100 successful projects delivered. Revenue model and customer count are not publicly available.
Core languages: Java, C++, C#. Client platforms: Windows, Android, iOS. Cloud: Azure, AWS, GCP. Frontend: Angular, JavaScript, HTML, CSS. DevOps: Jira, Azure DevOps. Design: Figma, Axure RP, Balsamiq.
Active projects include access-and-identity management, risk management, regulatory approval workflows for digital medical devices, automated data transfer to CRM, documentation digitalization, and email encryption—aligned with core pain points in regulatory compliance and data security.
Other companies in the same industry, closest in size